Fundz

Slingshot Biosciences Announces $23 Million In Series A Financing

PRIVATEJul 22, 2021

Amount Raised

$23 Million

Round Type

Series A

EmeryvilleOther

Description

Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform, today announced the closing of $23 million in a Series A financing. The investment was led by Northpond Ventures, with participation from ARCH Venture Partners and Anterra Capital. The new funding will enable Slingshot to accelerate the commercialization of its synthetic cell products spanning controls, diagnostics, and adoptive cell therapies. Adam Wieschhaus, PhD, Director at Northpond Ventures, and Corey Ritter, Senior Associate at ARCH Venture Partners, will join the Board of Directors

Quick answer

Slingshot Biosciences, Inc. raised $23 Million in a Series A round, dated July 22, 2021. Slingshot Biosciences, Inc. is based in Emeryville, California, United States.

How much did Slingshot Biosciences, Inc. raise?
Slingshot Biosciences, Inc. raised $23 Million in a Series A round on July 22, 2021.
What does Slingshot Biosciences, Inc. do?
Slingshot Biosciences develops synthetic cells for a range of applications in diagnostics and therapeutics.
Where is Slingshot Biosciences, Inc. based and how big is it?
Slingshot Biosciences, Inc. is based in Emeryville, California, United States. Fundz records about 61 employees.
Who are the decision-makers at Slingshot Biosciences, Inc?
Fundz holds 2 contacts at Slingshot Biosciences, Inc., including the Business Development Manager. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Slingshot Biosciences, Inc., and when

A new round usually means Slingshot Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Slingshot Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Slingshot Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Slingshot Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Slingshot Biosciences, Inc.

Location

1250 45TH STREET, SUITE 330

Emeryville, California, United States

About

Slingshot Biosciences develops synthetic cells for a range of applications in diagnostics and therapeutics. Slingshot leverages advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted toward a range of indications and markets. Learn more at www.slingshotbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Slingshot Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsTeri J. S., Business Development Manager hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Slingshot Biosciences, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Slingshot Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.